August 2021: This guideline is an update of NICE guideline CG182 (published July 2014), NICE guideline CG157 (published March 2013) and NICE guideline NG8 (published June 2015) and will replace them.
We have reviewed the evidence and made new recommendations on the assessment and management of chronic kidney disease, management of hyperphosphataemia in people with chronic kidney disease and the management of anaemia for people with chronic kidney disease. These recommendations are marked .
We have also made some changes without an evidence review:
We have updated some wording to bring the language and style up to date, without changing the meaning.
We have updated some recommendations to bring them in line with current terminology and practice.
We have combined, clarified or reworded some recommendations to make them clearer and to improve ease of reading.
In recommendations ending , [2006, amended 2011], [2006, amended 2015], , [2008, amended 2014], or , we have not reviewed the evidence. In some cases minor changes have been made – for example, to update links, or bring the language and style up to date – without changing the intent of the recommendation.